BE – Ajinomoto v. Helm et al. – Process for producing L-Lysine by fermentation

Posted: July 12th, 2010

Ajinomoto Co. Inc. v Helm AG et al., Antwerp Commercial Court, Belgium, 11 June 2010, Case nr. A/08/06919 The Antwerp commercial court finds the Belgian counterpart of Ajinomoto’s European patent nr. EP 0733710 B1 valid and infringed. EP ‘710 relates to a “process for producing L-lysine by fermentation”, particularly to a process applying a mutated […]


NL – Novozymes v. DSM Food Specialties

Posted: May 21st, 2010

Novozymes v. DSM Food Specialties, District Court The Hague, The Netherlands, 19 May 2010, with thanks to Simon Dack, De Brauw Blackstone Westbroek
Novozymes holds a European patent concerning a method preparing dough comprising, amongst other things, adding a lipolytic enzyme having activity towards digalactosyl diglyceride and the phospolipid (EP 1 131 416). Adding this lypolytic enzyme is said to help produce emulsifiers in the dough which would enhance its quality. DSM introduced its Panamore product, a direct competitor of Novozymes’ Lipopan products, in 2008. Novozymes is of the opinion that DSM’s Panamore product infringes on Novozymes European patent. DSM’s defends itself by…


UK – HTC Corporation v. Yozmot 33 Limited

Posted: April 21st, 2010

HTC Corporation v. Yozmot 33 Limited, Patents Court, Chancery Division, High Court of Justice, London, UK, 20 April 2010, [2010] EWHC 786 (Pat)
The Patents Court has held Yozmot’s patent EP (UK) 0 909 499 to be partially valid.
Yozmot’s patent concerned a boosted loudspeaker for a mobile telephone. Yozmot alleged


FR – Teva v. Sepracor / Invalidity (Enantiomers)

Posted: February 9th, 2010

Teva Classics SAS, Teva Sante SASU and Teva Pharmaceutical Industries Ltd v. Sepracor Inc, invalidity proceedings (enantiomers), Tribunal de Grande Instance, Paris, France, 6 October 2009, Docket No. 07/16446, with thanks to Pierre Véron, Véron & Associés
Cetirizine is a chiral molecule likely to exist in the form of two enantiomers


ES – Janssen v. Teva – Galantamine / Interim Injunction Appeal

Posted: November 16th, 2009

Janssen Pharmaceutica NV & Janssen-Cilag, S.A. v.Teva Genéricos Española, S.L., Court of Appeal (28th Section), Madrid, Spain, 16 November 2009, Docket No. 184/09 Section 28 of the Court of Appeal of Madrid has recently confirmed the first instance decision ordering Teva Genéricos Española (Teva) to temporarily refrain from commercializing in Spain generic drugs with the […]


FR – Otis v. Schindler (06/18186)

Posted: July 1st, 2009

Otis Elevator Company v. S.A. Schinlder, infringement and invalidity proceedings, Tribunal de Grande Instance, Paris, France, 1 July 2009, Docket No. 06/18186, with thanks to Pierre Véron, Véron & Associés Claim 1 of the foregoing patent is invalid for insufficient disclosure, the skilled person not being able to select the dimensions of the wedge clamp […]


FR – Johnson&Johnson v. Novartis

Posted: March 25th, 2009

Johnson&Johnson c.s. v. Novartis, infringement and invalidity proceedings, Tribunal de Grande Instance, Paris, France, 25 March 2009, Docket No. 07/13504, with thanks to Pierre Véron, Véron & Associés This action is part of the wider (ophthalmic lens) dispute between the same parties in the US, Australia and various European countries (Germany, Britain and Italy). Although […]


UK – Generics (UK) Limited and others v H Lundbeck A/S – House of Lords

Posted: February 25th, 2009

Generics (UK) Limited and others (Appellants) v H Lundbeck A/S (Respondents), House of Lords, UK, Case No. [2009] UKHL 12, with thanks to Marc Döring and Kevin Mooney, Simmons & Simmons
The Court of Appeal decision in Generics (UK) Limited v Lundbeck A/S followed